close

Syneron Medical Ltd. designs, develops, and markets aesthetic medical products. The company develops products based on its proprietary ELOS technology, which combines conducted radiofrequency energy, an electrical energy; and light or laser-based energy, an optical energy. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance, acne treatment, leg veins treatment, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, skin tightening, laser-assisted lipolysis, and dental laser. The company sells its products primarily to physicians and other practitioners, including plastic surgeons, aestheticians, medical spas, dentists, dermatologists, and cosmetic physicians. Syneron Medical Ltd. sells its products through a direct sales force in the United States and Canada, and through distributors in Europe, the Middle East, South Africa, the Asia-Pacific region, and South and Central America. The company was founded in 2000 and is headquartered in Yokneam Illit, Israel.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	10.97
Volume	75156
Volume Avg	131582
52 Week High	14.18
52 Week Low	8.91
PE	N/A
PE (group average)	39
EPS Year	-1.35
EPS change Q/Q	-90.54%
EPS change Q/Q Yr ago	-89.39%
EPS change Q/Q next Q est	1000%
EPS change Y/Y	-7.02%
REV change Q/Q	-73.72%
REV change Q/Q Yr ago	15.81%
EPS next Q est	0.05
EPS next Y est	0.59
Divident Annual	0.00
Dividend Yield	0%